Skip to main content
S 1128 113th Congress Senate

Preserving Access to Orphan Drugs Act of 2013

Official title: A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.

Introduced: June 11, 2013 See on congress.gov
Health Health care costs and insurancePrescription drugsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 11, 2013
Read twice and referred to the Committee on Finance.
Jun 11, 2013
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 11, 2013

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.

Makes this Act effective as if included in PPACA.

 Related & companion bills 1
  • HR 2315 Identical bill Preserving Access to Orphan Drugs Act of 2013
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 1 Republican 2
D
Murphy, Christopher
Connecticut · Jun 26, 2014
 R
Wicker, Roger F.
Mississippi · Jul 24, 2013
 R
Crapo, Mike
Idaho · Jun 11, 2013
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1128: Preserving Access to Orphan Drugs Act of 2013. 113th Congress. Open America. https://openamerica.io/bill/113-S-1128/
MLA
"S. 1128: Preserving Access to Orphan Drugs Act of 2013." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-1128/.
Bluebook (legal)
S. 1128, 113th Cong. (2026), https://openamerica.io/bill/113-S-1128/.
Markdown link
[S. 1128: Preserving Access to Orphan Drugs Act of 2013](https://openamerica.io/bill/113-S-1128/)
Report a problem